Vanguard Group’s Impax Laboratories, Inc. IPXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
|
|||||
|
2018
Q1 | $145M | Buy |
|
|||||
|
2017
Q4 | $117M | Buy |
|
|||||
|
2017
Q3 | $140M | Buy |
|
|||||
|
2017
Q2 | $110M | Buy |
|
|||||
|
2017
Q1 | $79.1M | Buy |
|
|||||
|
2016
Q4 | $79.2M | Sell |
|
|||||
|
2016
Q3 | $144M | Buy |
|
|||||
|
2016
Q2 | $162M | Buy |
|
|||||
|
2016
Q1 | $175M | Buy |
|
|||||
|
2015
Q4 | $221M | Buy |
|
|||||
|
2015
Q3 | $180M | Buy |
|
|||||
|
2015
Q2 | $226M | Buy |
|
|||||
|
2015
Q1 | $225M | Buy |
|
|||||
|
2014
Q4 | $145M | Buy |
|
|||||
|
2014
Q3 | $106M | Buy |
|
|||||
|
2014
Q2 | $132M | Buy |
|
|||||
|
2014
Q1 | $116M | Buy |
|
|||||
|
2013
Q4 | $106M | Buy |
|
|||||
|
2013
Q3 | $83M | Buy |
|
|||||
|
2013
Q2 | $78.8M | Buy |
|